Fungal Species: Psilocybe mushrooms

Psychedelics for the Treatment of Obsessive–Compulsive Disorder: Efficacy and Proposed Mechanisms

mycolabadmin

Psilocybin mushrooms show promise as a treatment for obsessive-compulsive disorder (OCD), a condition where people experience unwanted intrusive thoughts and compulsive behaviors. Current standard treatments with antidepressants don’t work for many patients and take weeks to show effects. Early research suggests psilocybin may reduce OCD symptoms quickly and works in treatment-resistant cases, though more rigorous studies are needed to confirm its effectiveness and understand how it works in the brain.

Read More »

Recent developments of tools for genome and metabolome studies in basidiomycete fungi and their application to natural product research

mycolabadmin

Mushrooms and related fungi in the basidiomycete group produce many useful medicines and agricultural chemicals. Scientists have traditionally struggled to study these fungi because they grow slowly and have complex genomes. Recent technological breakthroughs—including faster DNA sequencing and gene-editing tools—are now making it much easier to discover and understand the helpful compounds these fungi produce, potentially leading to new medicines.

Read More »

Scalable Hybrid Synthetic/Biocatalytic Route to Psilocybin

mycolabadmin

Researchers developed a new method to manufacture psilocybin, a promising therapeutic compound from magic mushrooms being tested to treat depression. Instead of using toxic chemicals, they replaced a difficult chemical step with an enzyme from the mushroom itself called PsiK. This approach produced gram amounts of pure psilocybin efficiently and could eventually lower costs for future medical use.

Read More »

Pharmacokinetics of Psilocybin: A Systematic Review

mycolabadmin

This review examines how the body processes psilocybin, a compound from magic mushrooms being studied for treating depression and anxiety. When taken orally, psilocybin is quickly converted to its active form, psilocin, which reaches peak levels in the bloodstream within 1-4 hours and is eliminated mainly through urine. The body’s ability to process psilocybin involves specific liver enzymes that vary between individuals, potentially explaining why people respond differently to the same dose and why certain medications can interfere with its effects.

Read More »

Mycotherapy: Potential of Fungal Bioactives for the Treatment of Mental Health Disorders and Morbidities of Chronic Pain

mycolabadmin

This research explores how compounds from mushrooms could provide new treatments for mental health conditions and chronic pain. Traditional mushroom-based medicines are being scientifically studied as potential alternatives to current psychiatric medications, especially for patients who don’t respond well to existing treatments. The studies show promising results with fewer side effects than conventional drugs. Impacts on everyday life: – Could provide new treatment options for people suffering from depression and anxiety who haven’t found relief with current medications – May offer safer alternatives with fewer side effects than existing psychiatric drugs – Could help reduce chronic pain without the risks associated with opioid medications – May provide faster-acting treatments for mental health conditions compared to current options that take weeks to work – Could lead to new ways of treating addiction and PTSD that are more effective than current methods

Read More »
Scroll to Top